TYCOON GROUP HOLDINGS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.05 HKD | +0.50% |
|
+2.02% | -12.34% |
| Sales 2022 | 1.19B 152M 12.64B | Sales 2023 | 1.2B 153M 12.78B | Capitalization | 3.7B 472M 39.39B |
|---|---|---|---|---|---|
| Net income 2022 | 43M 5.49M 458M | Net income 2023 | 297M 37.95M 3.17B | EV / Sales 2022 | 1.68 x |
| Net Debt 2022 | 267M 34.12M 2.85B | Net Debt 2023 | 167M 21.35M 1.78B | EV / Sales 2023 | 3.22 x |
| P/E ratio 2022 |
38.4
x | P/E ratio 2023 |
12.2
x | Employees | 130 |
| Yield 2022 |
1.4% | Yield 2023 |
1.52% | Free-Float | 17.93% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.50% | ||
| 1 week | +2.02% | ||
| Current month | -2.88% | ||
| 3 months | -22.86% | ||
| 6 months | -18.67% | ||
| Current year | -12.34% |
1 week
3.97
4.07
1 month
2.914.18
Current year
2.915.95
1 year
2.915.95
3 years
1.096.25
5 years
0.856.25
10 years
0.856.25
| Managers | Title | Age | Since |
|---|---|---|---|
Ka Chun Wong
CEO | Chief Executive Officer | 48 | 01/15/01 |
Yu Hei Chan
SAM | Sales & Marketing | 37 | 06/17/06 |
Lai Yuk Tsang
SAM | Sales & Marketing | 54 | 19/17/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ka On Lau
BRD | Director/Board Member | 49 | 01/21/01 |
Ka Lai Chan
BRD | Director/Board Member | 50 | 20/20/20 |
Ka Chun Wong
CEO | Chief Executive Officer | 48 | 01/15/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 4.05 | +0.50% | 154 000 |
| 26/24/26 | 4.03 | +0.25% | 256,000 |
| 25/24/25 | 4.02 | -0.25% | 650,000 |
| 24/24/24 | 4.03 | 0.00% | 1,190,000 |
| 23/24/23 | 4.03 | +1.51% | 446,000 |
Delayed Quote Hong Kong S.E., April 29, 2024 at 12:10 pm IST
More quotes
Tycoon Group Holdings Ltd is an investment holding company principally engaged in the provision of proprietary Chinese medicine (PCM) and health supplement products. Together with its subsidiaries, the Company operates business through its three operating segments. The Distribution segment is engaged in the operation of distributing products to chain retailers, non-chain retailers and traders. The Retail Stores segment is involved in the operation of retail stores. The Online Stores segment is involved in the operation of retail store online stores. The Company is also engaged in the provision of skin care, personal care and other healthcare products.
Sector
Pharmaceuticals
Calendar
29/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -12.34% | 412M | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| -0.73% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B |
- Stock Market
- Equities
- 3390 Stock
